Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 21Head & Neck 5Breast 5Thoracic 4Gastrointestinal 4Sarcoma 3Lymphoid 2Gynecologic 2Dermatologic 2Other solid neoplasm 1Myeloid 1CNS 1

Conditions

Brain Neoplasms 285Glioblastoma 248Glioma 196Neuroblastoma 86Neoplasms 62Central Nervous System Neoplasms 54Astrocytoma 54Medulloblastoma 47Breast Neoplasms 43Sarcoma 39Meningioma 39Melanoma 38Neurofibromatosis 1 36Lung Neoplasms 36Ependymoma 35Carcinoma, Non-Small-Cell Lung 35Osteosarcoma 31Rhabdomyosarcoma 30Sarcoma, Ewing 27Rhabdoid Tumor 27Neoplasm Metastasis 27Diffuse Intrinsic Pontine Glioma 27Recurrence 26Oligodendroglioma 23Wilms Tumor 21Gliosarcoma 21Pheochromocytoma 20Pancreatic Neoplasms 20Hepatoblastoma 20Meningeal Carcinomatosis 19

Interventions

temsirolimus 1Valproic Acid 1Sirolimus 1Immunoglobulin G 1Disulfides 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × CNS × 90 days × Clear all
NCT01552434 2026-05-15

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
154 enrolled
BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡